Auxiliary Diagnosis for COVID-19 with Deep Transfer Learning

Diagnostic performance of deep learning models versus radiologists in COVID-19 pneumonia: A systematic review and meta-analysis

PURPOSE

Although several studies have compared the performance of deep learning (DL) models and radiologists for the diagnosis of COVID-19 pneumonia on CT of the chest, these results have not been collectively evaluated. We performed a meta-analysis of original articles comparing the performance of DL models versus radiologists in detecting COVID-19 pneumonia.

METHODS

A systematic search was conducted on the three main medical literature databases, Scopus, Web of Science, and PubMed, for articles published as of February 1st, 2023. We included original scientific articles that compared DL models trained to detect COVID-19 pneumonia on CT to radiologists. Meta-analysis was performed to determine DL versus radiologist performance in terms of model sensitivity and specificity, taking into account inter and intra-study heterogeneity.

RESULTS

Twenty-two articles met the inclusion criteria. Based on the meta-analytic calculations, DL models had significantly higher pooled sensitivity (0.933 vs. 0.829, p < 0.001) compared to radiologists with similar pooled specificity (0.905 vs. 0.897, p = 0.746). In the differentiation of COVID-19 versus community-acquired pneumonia, the DL models had significantly higher sensitivity compared to radiologists (0.915 vs. 0.836, p = 0.001).

CONCLUSIONS

DL models have high performance for screening of COVID-19 pneumonia on chest CT, offering the possibility of these models for augmenting radiologists in clinical practice.

Robust Medical Diagnosis: A Novel Two-Phase Deep Learning Framework for Adversarial Proof Disease Detection in Radiology Images

In the realm of medical diagnostics, the utilization of deep learning techniques, notably in the context of radiology images, has emerged as a transformative force. The significance of artificial intelligence (AI), specifically machine learning (ML) and deep learning (DL), lies in their capacity to rapidly and accurately diagnose diseases from radiology images. This capability has been particularly vital during the COVID-19 pandemic, where rapid and precise diagnosis played a pivotal role in managing the spread of the virus. DL models, trained on vast datasets of radiology images, have showcased remarkable proficiency in distinguishing between normal and COVID-19-affected cases, offering a ray of hope amidst the crisis. However, as with any technological advancement, vulnerabilities emerge. Deep learning-based diagnostic models, although proficient, are not immune to adversarial attacks. These attacks, characterized by carefully crafted perturbations to input data, can potentially disrupt the models' decision-making processes. In the medical context, such vulnerabilities could have dire consequences, leading to misdiagnoses and compromised patient care. To address this, we propose a two-phase defense framework that combines advanced adversarial learning and adversarial image filtering techniques. We use a modified adversarial learning algorithm to enhance the model's resilience against adversarial examples during the training phase. During the inference phase, we apply JPEG compression to mitigate perturbations that cause misclassification. We evaluate our approach on three models based on ResNet-50, VGG-16, and Inception-V3. These models perform exceptionally in classifying radiology images (X-ray and CT) of lung regions into normal, pneumonia, and COVID-19 pneumonia categories. We then assess the vulnerability of these models to three targeted adversarial attacks: fast gradient sign method (FGSM), projected gradient descent (PGD), and basic iterative method (BIM). The results show a significant drop in model performance after the attacks. However, our defense framework greatly improves the models' resistance to adversarial attacks, maintaining high accuracy on adversarial examples. Importantly, our framework ensures the reliability of the models in diagnosing COVID-19 from clean images.

A Systematic Review on Deep Structured Learning for COVID-19 Screening Using Chest CT from 2020 to 2022

The emergence of the COVID-19 pandemic in Wuhan in 2019 led to the discovery of a novel coronavirus. The World Health Organization (WHO) designated it as a global pandemic on 11 March 2020 due to its rapid and widespread transmission. Its impact has had profound implications, particularly in the realm of public health. Extensive scientific endeavors have been directed towards devising effective treatment strategies and vaccines. Within the healthcare and medical imaging domain, the application of artificial intelligence (AI) has brought significant advantages. This study delves into peer-reviewed research articles spanning the years 2020 to 2022, focusing on AI-driven methodologies for the analysis and screening of COVID-19 through chest CT scan data. We assess the efficacy of deep learning algorithms in facilitating decision making processes. Our exploration encompasses various facets, including data collection, systematic contributions, emerging techniques, and encountered challenges. However, the comparison of outcomes between 2020 and 2022 proves intricate due to shifts in dataset magnitudes over time. The initiatives aimed at developing AI-powered tools for the detection, localization, and segmentation of COVID-19 cases are primarily centered on educational and training contexts. We deliberate on their merits and constraints, particularly in the context of necessitating cross-population train/test models. Our analysis encompassed a review of 231 research publications, bolstered by a meta-analysis employing search keywords (COVID-19 OR Coronavirus) AND chest CT AND (deep learning OR artificial intelligence OR medical imaging) on both the PubMed Central Repository and Web of Science platforms.

Optimized Xception Learning Model and XgBoost Classifier for Detection of Multiclass Chest Disease from X-ray Images

Computed tomography (CT) scans, or radiographic images, were used to aid in the early diagnosis of patients and detect normal and abnormal lung function in the human chest. However, the diagnosis of lungs infected with coronavirus disease 2019 (COVID-19) was made more accurately from CT scan data than from a swab test. This study uses human chest radiography pictures to identify and categorize normal lungs, lung opacities, COVID-19-infected lungs, and viral pneumonia (often called pneumonia). In the past, several CAD systems using image processing, ML/DL, and other forms of machine learning have been developed. However, those CAD systems did not provide a general solution, required huge hyper-parameters, and were computationally inefficient to process huge datasets. Moreover, the DL models required high computational complexity, which requires a huge memory cost, and the complexity of the experimental materials' backgrounds, which makes it difficult to train an efficient model. To address these issues, we developed the Inception module, which was improved to recognize and detect four classes of Chest X-ray in this research by substituting the original convolutions with an architecture based on modified-Xception (m-Xception). In addition, the model incorporates depth-separable convolution layers within the convolution layer, interlinked by linear residuals. The model's training utilized a two-stage transfer learning process to produce an effective model. Finally, we used the XgBoost classifier to recognize multiple classes of chest X-rays. To evaluate the m-Xception model, the 1095 dataset was converted using a data augmentation technique into 48,000 X-ray images, including 12,000 normal, 12,000 pneumonia, 12,000 COVID-19 images, and 12,000 lung opacity images. To balance these classes, we used a data augmentation technique. Using public datasets with three distinct train-test divisions (80-20%, 70-30%, and 60-40%) to evaluate our work, we attained an average of 96.5% accuracy, 96% F1 score, 96% recall, and 96% precision. A comparative analysis demonstrates that the m-Xception method outperforms comparable existing methods. The results of the experiments indicate that the proposed approach is intended to assist radiologists in better diagnosing different lung diseases.

Deep efficient-nets with transfer learning assisted detection of COVID-19 using chest X-ray radiology imaging

Corona Virus (COVID-19) could be considered as one of the most devastating pandemics of the twenty-first century. The effective and the rapid screening of infected patients could reduce the mortality and even the contagion rate. Chest X-ray radiology could be designed as one of the effective screening techniques for COVID-19 exploration. In this paper, we propose an advanced approach based on deep learning architecture to automatic and effective screening techniques dedicated to the COVID-19 exploration through chest X-ray (CXR) imaging. Despite the success of state-of-the-art deep learning-based models for COVID-19 detection, they might suffer from several problems such as the huge memory and the computational requirement, the overfitting effect, and the high variance. To alleviate these issues, we investigate the Transfer Learning to the Efficient-Nets models. Next, we fine-tuned the whole network to select the optimal hyperparameters. Furthermore, in the preprocessing step, we consider an intensity-normalization method succeeded by some data augmentation techniques to solve the imbalanced dataset classes' issues. The proposed approach has presented a good performance in detecting patients attained by COVID-19 achieving an accuracy rate of 99.0% and 98% respectively using training and testing datasets. A comparative study over a publicly available dataset with the recently published deep-learning-based architectures could attest the proposed approach's performance.

Diagnostic performance of corona virus disease 2019 chest computer tomography image recognition based on deep learning: Systematic review and meta-analysis

BACKGROUND

To analyze the diagnosis performance of deep learning model used in corona virus disease 2019 (COVID-19) computer tomography(CT) chest scans. The included sample contains healthy people, confirmed COVID-19 patients and unconfirmed suspected patients with corresponding symptoms.

METHODS

PubMed, Web of Science, Wiley, China National Knowledge Infrastructure, WAN FANG DATA, and Cochrane Library were searched for articles. Three researchers independently screened the literature, extracted the data. Any differences will be resolved by consulting the third author to ensure that a highly reliable and useful research paper is produced. Data were extracted from the final articles, including: authors, country of study, study type, sample size, participant demographics, type and name of AI software, results (accuracy, sensitivity, specificity, ROC, and predictive values), other outcome(s) if applicable.

RESULTS

Among the 3891 searched results, 32 articles describing 51,392 confirmed patients and 7686 non-infected individuals met the inclusion criteria. The pooled sensitivity, the pooled specificity, positive likelihood ratio, negative likelihood ratio and the pooled diagnostic odds ratio (OR) is 0.87(95%CI [confidence interval]: 0.85, 0.89), 0.85(95%CI: 0.82, 0.87), 6.7(95%CI: 5.7, 7.8), 0.14(95%CI: 0.12, 0.16), and 49(95%CI: 38, 65). Further, the AUROC (area under the receiver operating characteristic curve) is 0.94(95%CI: 0.91, 0.96). Secondary outcomes are specific sensitivity and specificity within subgroups defined by different models. Resnet has the best diagnostic performance, which has the highest sensitivity (0.91[95%CI: 0.87, 0.94]), specificity (0.90[95%CI: 0.86, 0.93]) and AUROC (0.96[95%CI: 0.94, 0.97]), according to the AUROC, we can get the rank Resnet > Densenet > VGG > Mobilenet > Inception > Effficient > Alexnet.

CONCLUSIONS

Our study findings show that deep learning models have immense potential in accurately stratifying COVID-19 patients and in correctly differentiating them from patients with other types of pneumonia and normal patients. Implementation of deep learning-based tools can assist radiologists in correctly and quickly detecting COVID-19 and, consequently, in combating the COVID-19 pandemic.

Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective

Multiplex assays that provide simultaneous measurement of multiple analytes in biological samples have now developed into widely used technologies in the study of diseases, drug discovery, and other medical areas. These approaches span multiple assay systems and can provide readouts of specific assay components with similar accuracy as the respective single assay measurements. Multiplexing allows the consumption of lower sample volumes, lower costs, and higher throughput compared with carrying out single assays. A number of recent studies have demonstrated the impact of multiplex assays in the study of the SARS-CoV-2 virus, the infectious agent responsible for the current COVID-19 pandemic. In this respect, machine learning techniques have proven to be highly valuable in capturing complex disease phenotypes and converting these insights into models which can be applied in real-world settings. This chapter gives an overview of opportunities and challenges of multiplexed biomarker analysis, with a focus on the use of machine learning aimed at identification of biological signatures for increasing our understanding of COVID-19 disease, and for improved diagnostics and prediction of disease outcomes.